Workflow
国药集团国瑞药业有限公司信用等级被评严重失信
Zhong Guo Jing Ji Wang·2025-08-05 10:19

Core Viewpoint - Heilongjiang Province's Public Resource Trading Center has published the credit evaluation results for pharmaceutical pricing and procurement, highlighting that China National Pharmaceutical Group Guorui Pharmaceutical Co., Ltd. has been rated as "seriously untrustworthy" due to violations of good faith practices [1][2]. Group 1: Company Information - China National Pharmaceutical Group Guorui Pharmaceutical Co., Ltd. was originally known as Huainan Sixth Pharmaceutical Factory, established in 1986, and became part of China National Pharmaceutical Group in 1998 [2]. - The company is a significant industrial strategic development base for China National Pharmaceutical Group [2]. Group 2: Products Involved - The serious untrustworthiness rating involves two products: injectable cefoperazone sodium and injectable betahistine hydrochloride [2]. - Injectable betahistine hydrochloride is a key product for the company and is noted as a unique product in the country [2]. Group 3: Evaluation Results - The credit evaluation results indicate that the serious untrustworthiness rating for the company became effective on May 30, 2025 [2].